Overhauling oversight—European drug legislation

被引：0
|
作者：
Lincoln Tsang
机构：
[1] member of the Pharmaceutical and Medical Devices Regulatory Practice of Arnold & Porter LLP,
[2] based in Tower 42,undefined
来源：
Nature Biotechnology | 2005年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
At the end of next month, the European Medicines Agency (EMEA) will implement a new legislative framework and several provisions that seek to provide incentives and streamline regulatory oversight of certain monoclonal antibodies and other biologic products.
引用
收藏
页码：1050 / 1053
页数：3
相关论文
共 50 条
12345